BamSEC and AlphaSense Join Forces
Learn More

Apogee Therapeutics Inc.

NASDAQ: APGE    
Share price (12/24/24): $47.32    
Market cap (12/24/24): $2.769 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.5
from 10-Q 4 pages Third Amendment to License Agreement
12/34/56
EX-10.4
from 10-Q 3 pages Second Amendment to License Agreement
12/34/56
EX-10.3
from 10-Q 3 pages First Amendment to License Agreement
12/34/56
EX-10.2
from 10-Q 13 pages License Agreement
12/34/56
EX-10.1
from 10-Q 3 pages First Amendment to the Apogee Therapeutics, Inc. 2023 Employee Stock Purchase Plan [Signature Page Follows]
12/34/56
EX-10.6
from 10-K 7 pages Apogee Therapeutics, Inc. 2023 Equity Incentive Plan Grant Notice for Restricted Stock Unit Award
12/34/56
EX-10.7
from 10-Q 26 pages Antibody Discovery and Option Agreement
12/34/56
EX-10.9
from 10-Q 22 pages ​ Apogee Therapeutics, Inc. 2023 Equity Incentive Plan
12/34/56
EX-10.4
from 10-Q 8 pages Executive Employment Agreement
12/34/56
EX-10.3
from 10-Q 9 pages Executive Employment Agreement
12/34/56
EX-10.2
from 10-Q 9 pages Amended and Restated Executive Employment Agreement
12/34/56
EX-10.15
from S-1/A 16 pages Apogee Therapeutics, Inc. 2023 Employee Stock Purchase Plan
12/34/56
EX-10.14
from S-1/A 21 pages Apogee Therapeutics, Inc. 2023 Equity Incentive Plan
12/34/56
EX-10.15
from S-1/A 16 pages Apogee Therapeutics, Inc. 2023 Employee Stock Purchase Plan
12/34/56
EX-10.14
from S-1/A 21 pages Apogee Therapeutics, Inc. 2023 Equity Incentive Plan
12/34/56
EX-10.1
from S-1/A 10 pages Indemnification Agreement
12/34/56
EX-10.13
from S-1 4 pages Novation Agreement
12/34/56
EX-10.12
from S-1 18 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Cell Line License Agreement
12/34/56
EX-10.11
from S-1 25 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Biologics Master Services Agreement
12/34/56
EX-10.10
from S-1 37 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. License Agreement
12/34/56